Christian Lavedan
Vanda Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Genetic Neurodegenerative Diseases, Nuclear Receptors and Signaling, Circadian rhythm and melatonin, Mitochondrial Function and Pathology
Most-Cited Works
- → Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease(1997)8,181 cited
- → The ubiquitin pathway in Parkinson's disease(1998)1,566 cited
- → The Synuclein Family(1998)319 cited
- → Tasimelteon for non-24-hour sleep–wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials(2015)292 cited
- Myotonic dystrophy: size- and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism.(1993)
- → Applicability of a Genetic Signature for Enhanced Iloperidone Efficacy in the Treatment of Schizophrenia(2009)205 cited
- → Identification, localization and characterization of the human γ-synuclein gene(1998)173 cited
- → Deletions in the Parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson's disease(1998)157 cited
- → Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study(2008)154 cited
- → Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia(2008)104 cited